Antiviral Bioactive Compounds of Mushrooms

Antiviral Bioactive Compounds of Mushrooms: Comparison

Please note this is a comparison between Version 2 by Lily Guo and Version 1 by Dong Joo Seo.

Mushrooms are used in their natural form as a food supplement and food additive. In addition, several bioactive compounds beneficial for human health have been derived from mushrooms. Among them, polysaccharides, carbohydrate-binding protein, peptides, proteins, enzymes, polyphenols, triterpenes, triterpenoids, and several other compounds exert antiviral activity against DNA and RNA viruses. Their antiviral targets were mostly virus entry, viral genome replication, viral proteins, and cellular proteins and influenced immune modulation, which was evaluated through pre-, simultaneous-, co-, and post-treatment in vitro and in vivo studies. In particular, they treated and relieved the viral diseases caused by herpes simplex virus, influenza virus, and human immunodeficiency virus (HIV). Some mushroom compounds that act against HIV, influenza A virus, and hepatitis C virus showed antiviral effects comparable to those of antiviral drugs. Therefore, bioactive compounds from mushrooms could be candidates for treating viral infections.

mushroom
bioactive compound
virus
infection
antiviral mechanism

Please wait, diff process is still running!

References

Cheung, P.C. Mushrooms as Functional Foods; Cheung, P.C.K., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 2008.
Rahi, D.K.; Malik, D. Diversity of mushrooms and their metabolites of nutraceutical and therapeutic significance. J. Mycol. 2016, 2016, 1–18.
Carter, J.; Saunders, V.A. Virology: Principles and Applications, 2nd ed.; John Wiley & Sons: Hoboken, NJ, USA, 2013.
Menéndez-Arias, L.; Álvarez, M. Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection. Antivir. Res. 2014, 102, 70–86.
Tsai, H.C.; Chen, I.T.; Wu, K.S.; Tseng, Y.T.; Sy, C.L.; Chen, J.K.; Lee, S.S.J.; Chen, Y.S. High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014. Infect. Drug resist. 2017, 10, 343.
Omotani, S.; Ishizaka, T.; Inoue, M.; Nishida, K.; Yasui, Y.; Hatsuda, Y.; Mukai, J.; Myotoku, M. Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir. JPHCS 2020, 6, 1–5.
Jacobs, A.; Breakefield, X.O.; Fraefel, C. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: Part I. HSV-1 structure, replication and pathogenesis. Neoplasia 1999, 1, 387–401.
Zając, M.; Muszalska, I.; Sobczak, A.; Dadej, A.; Tomczak, S.; Jelińska, A. Hepatitis C–New drugs and treatment prospects. Eur. J. Med. Chem. 2019, 165, 225–249.
Santoyo, S.; Ramírez-Anguiano, A.C.; Aldars-García, L.; Reglero, G.; Soler-Rivas, C. Antiviral activities of Boletus edulis, Pleurotus ostreatus and Lentinus edodes extracts and polysaccharide fractions against Herpes simplex virus type 1. J. Food Nutr. Res. 2012, 51, 225–235.
Lee, S.M.; Kim, S.M.; Lee, Y.H.; Kim, W.J.; Park, J.K.; Park, Y.I.; Jang, W.J.; Shin, H.; Synytsya, A. Macromolecules isolated from Phellinus pini fruiting body: Chemical characterization and antiviral activity. Macromol. Res. 2010, 18, 602–609.
Niedermeyer, T.H.; Lindequist, U.; Mentel, R.; Gördes, D.; Schmidt, E.; Thurow, K.; Lalk, M. Antiviral Terpenoid Constituents of Ganoderma pfeifferi. J. Nat. Prod. 2005, 68, 1728–1731.
Mothana, R.; Ali, N.A.; Jansen, R.; Wegner, U.; Mentel, R.; Lindequist, U. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia 2003, 74, 177–180.
Yan, N.; He, F.; Piraino, F.F.; Xiang, H.; Chen, J.; Wang, Y.; Liu, X. Antiviral activity of a cloned peptide RC28 isolated from the higher basidiomycetes mushroom Rozites caperata in a mouse model of HSV-1 keratitis. Int. J. Med. Mushrooms 2015, 17, 819–828.
De Sousa Cardozo, F.T.G.; Camelini, C.M.; Mascarello, A.; Rossi, M.J.; Nunes, R.J.; Barardi, C.R.M.; de Mendonça, M.M.; Simões, C.M.O. Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia. Antivir. Res. 2011, 92, 108–114.
Cardozo, F.; Larsen, I.V.; Carballo, E.V.; Jose, G.; Stern, R.A.; Brummel, R.C.; Camelini, C.M.; Rossi, M.J.; Simões, C.; Brandt, C.R. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide. Antimicrob. Agents Chemother. 2013, 57, 2541–2549.
Liu, J.; Yang, F.; Ye, L.; Yang, X.; Timani, K.A.; Zheng, Y.; Wang, Y. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J. Ethnopharmacol. 2004, 95, 265–272.
Li, Z.; Liu, J.; Zhao, Y. Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. BMB Rep. 2005, 38, 34–40.
Ilyicheva, T.N.; Teplyakova, T.V.; Svyatchenko, S.V.; Asbaganov, S.V.; Zmitrovich, I.V.; Vlasenko, A.V. Antiviral activity of total polysaccharide fraction of water and ethanol extracts of Pleurotus pulmonarius against the influenza A virus. Curr. Res. Environ. Appl. Mycol. J. Fungal Biol. 2020, 10, 224–235.
Ohta, Y.; Lee, J.; Hayashi, K.; Fujita, A.; Park, D.K.; Hayashi, T. In vivo anti-influenza virus activity of an immunomodulatory acidic polysaccharide isolated from Cordyceps militaris grown on germinated soybeans. J. Agric. Food Chem. 2007, 55, 10194–10199.
Hwang, B.S.; Lee, M.; Lee, S.W.; Lee, I.; Seo, G.; Choi, H.J.; Yun, B. Neuraminidase inhibitors from the fermentation broth of Phellinus linteus. Mycobiology 2014, 42, 189–192.
Suzuki, F.; Suzuki, C.; Shimomura, E.; Maeda, H.; Fujil, T.; Ishida, N. Antiviral and interferon-inducing activities of a new peptidomannan, KS-2, extracted from culture mycelia of Lentinus edodes. J. Antibiot. 1979, 32, 1336–1345.
Hwang, B.S.; Lee, I.; Choi, H.J.; Yun, B. Anti-influenza activities of polyphenols from the medicinal mushroom Phellinus baumii. Bioorg. Med. Chem. Lett. 2015, 25, 3256–3260.
Song, A.; Sun, X.; Kong, C.; Zhao, C.; Qin, D.; Huang, F.; Yang, S. Discovery of a new sesquiterpenoid from Phellinus ignarius with antiviral activity against influenza virus. Arch. Virol. 2014, 159, 753–760.
Adotey, G.; Quarcoo, A.; Holliday, J.; Fofie, S.; Saaka, B. Effect of immunomodulating and antiviral agent of medicinal mushrooms (immune assist 24/7 TM) on CD4 T-lymphocyte counts of HIV-infected patients. Int. J. Med. Mushrooms 2011, 13, 109–113.
Wang, C.R.; Ng, T.B.; Li, L.; Fang, J.C.; Jiang, Y.; Wen, T.Y.; Qiao, W.T.; Li, N.; Liu, F. Isolation of a polysaccharide with antiproliferative, hypoglycemic, antioxidant and HIV-1 reverse transcriptase inhibitory activities from the fruiting bodies of the abalone mushroom Pleurotus abalonus. J. Pharm. Pharmacol. 2011, 63, 825–832.
Collins, R.A.; Ng, T.B. Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sci. 1997, 60, PL383–PL387.
Wang, H.X.; Ng, T.B. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Med. 2001, 67, 669–672.
Li, Y.R.; Liu, Q.H.; Wang, H.X.; Ng, T.B. A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus. Biochim. Biophys. Acta-Gen. Subjects 2008, 1780, 51–57.
Ngai, P.H.; Ng, T.B. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci. 2003, 73, 3363–3374.
Wang, H.X.; Ng, T.B. Isolation of a novel ubiquitin-like protein from Pleurotus ostreatus mushroom with anti-human immunodeficiency virus, translation-inhibitory, and ribonuclease activities. Biochem. Biophys. Res. Commun. 2000, 276, 587–593.
Wang, J.; Wang, H.X.; Ng, T.B. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa. Peptides 2007, 28, 560–565.
Wang, H.X.; Ng, T.B. Purification of a novel low-molecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum. Biochem. Biophys. Res. Commun. 2004, 315, 450–454.
Lv, H.; Kong, Y.; Yao, Q.; Zhang, B.; Leng, F.; Bian, H.; Balzarini, J.; Van Damme, E.; Bao, J. Nebrodeolysin, a novel hemolytic protein from mushroom Pleurotus nebrodensis with apoptosis-inducing and anti-HIV-1 effects. Phytomedicine 2009, 16, 198–205.
M EL-Fakharany, E.; M Haroun, B.; Ng, T.; M Redwan, E. Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells. Protein Peptide Lett. 2010, 17, 1031–1039.
Lopez-Tejedor, D.; Claveria-Gimeno, R.; Velazquez-Campoy, A.; Abian, O.; Palomo, J.M. Tyrosinase from mushroom Agaricus bisporus as an inhibitor of the Hepatitis C virus. bioRxiv. 2020.
Seo, D.J.; Choi, C. Inhibition of murine norovirus and feline calicivirus by edible herbal extracts. Food Environ. Virol. 2017, 9, 35–44.
Tian, J.; Hu, X.; Liu, D.; Wu, H.; Qu, L. Identification of Inonotus obliquus polysaccharide with broad-spectrum antiviral activity against multi-feline viruses. Int. J. Biol. Macromol. 2017, 95, 160–167.
Zhao, C.; Gao, L.; Wang, C.; Liu, B.; Jin, Y.; Xing, Z. Structural characterization and antiviral activity of a novel heteropolysaccharide isolated from Grifola frondosa against enterovirus 71. Carbohydr. Polym. 2016, 144, 382–389.
Zhang, W.; Tao, J.; Yang, X.; Yang, Z.; Zhang, L.; Liu, H.; Wu, K.; Wu, J. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem. Biophys. Res. Commun. 2014, 449, 307–312.
Faccin, L.C.; Benati, F.; Rincao, V.P.; Mantovani, M.S.; Soares, S.A.; Gonzaga, M.L.; Nozawa, C.; Carvalho Linhares, R.E. Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1. Lett. Appl. Microbiol. 2007, 45, 24–28.
Rincão, V.P.; Yamamoto, K.A.; Ricardo, N.M.P.S.; Soares, S.A.; Meirelles, L.D.P.; Nozawa, C.; Linhares, R.E.C. Polysaccharide and extracts from Lentinula edodes: Structural features and antiviral activity. Virol. J. 2012, 9, 37.
Nishiyama, Y. Herpesvirus genes: Molecular basis of viral replication and pathogenicity. Nagoya J. Med. Sci. 1996, 59, 107–120.
Birkmann, A.; Zimmermann, H. HSV antivirals–current and future treatment options. Curr. Opin. Virol. 2016, 18, 9–13.
Dou, D.; Revol, R.; Östbye, H.; Wang, H.; Daniels, R. Influenza A virus cell entry, replication, virion assembly and movement. Front. Immunol. 2018, 9, 1–17.
Moscona, A. Neuraminidase inhibitors for influenza. N. Engl. J. Med. 2005, 353, 1363–1373.
Takashita, E.; Morita, H.; Ogawa, R.; Nakamura, K.; Fujisaki, S.; Shirakura, M.; Kuwahara, T.; Kishida, N.; Watanabe, S.; Odagiri, T. Susceptibility of influenza viruses to the novel cap-dependent endonuclease inhibitor baloxavir marboxil. Front. Microbiol. 2018, 9, 3026.
Kapadia, S.B.; Chisari, F.V. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA 2005, 102, 2561–2566.
Kotwal, G.; Cannon, J.L. Environmental persistence and transfer of enteric viruses. Curr. Opin. Virol. 2014, 4, 37–43.
Li, D.; Baert, L.; Uyttendaele, M. Inactivation of food-borne viruses using natural biochemical substances. Food Microbiol. 2013, 35, 1–9.
International Committee on Taxonomy of Viruses (ICTV). Available online: (accessed on 6 November 2020).
Abzug, M.J. The enteroviruses: Problems in need of treatments. J. Infect. 2014, 68, S108–S114.